Price
No data yet.
Social Signal Score
Revenue
$0.00-100.00%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Robert A. Berman
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 33
- Beta
- 1.07
- Country
- US
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- -12.24
Financials
Revenue
$0.00-100.0%Net Income
$-3.60MEBITDA
$-3.60MFree Cash Flow
$-3.55MEPS (diluted)
$-5.37Shares Outstanding (diluted)
671.0K+187330.2%Operating Expenses
$3.80MCash & Debt
$21.49MRevenue by Segment (annual)
$31.2KQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-19.47M | $-33.06 |
| 2024 | $0.00 | $-21.82M | $-1555.75 |
| 2023 | $0.00 | $-23.52M | $-2339.75 |
| 2022 | $0.00 | $-24.67M | $-2695.00 |
| 2021 | $0.00 | $-16.53M | $-2327.50 |
| 2020 | $0.00 | $-9.14M | $-9236.50 |
| 2019 | $31.2K | $-7.63M | $-14822.50 |
| 2018 | $186.6K | $-13.04M | $-53495.75 |
| 2017 | $422.1K | $-7.79M | $-26068.00 |
| 2016 | $785.9K | $-5.89M | $-10412.50 |
| 2015 | $0.00 | $-1.60M | $-4483.50 |
| 2014 | $236.5K | $-1.40M | $-5194.00 |
Valuation
NVNOhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+0.00%Social Signal Score
Mentions (2)
- Newsaccessnewswire.com·1d ago·Neutral
enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-Demand Access the video webcast here IRVINE, CA / ACCESS Newswire / September 11, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today announced that its pre-recorded presentation from the H.C. Wainwright 28th Annual Global Investment Conference is now available for on-demand viewing here.
View source ↗ - Newsaccessnewswire.com·16d ago·Neutral
enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference Video Webcast Now Available Here IRVINE, CA / ACCESS Newswire / August 27, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company") today announced that Robert Berman, Chief Executive Officer of enVVeno Medical, participated in the Virtual Investor "Why Now" on-demand conference. For the event, Mr.
View source ↗
Earnings
Fri, Oct 30(in 7 weeks)
Consensus estimate $-3.27 per share
Typical surprise -14.5% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 30$-5.37 vs $-4.69miss
- Thu, May 7$-5.89 vs $-8.40beat
- Thu, Mar 26$-227.07 vs $-9.80miss
- Wed, Oct 29$-281.75 vs $-10.50miss
- Wed, Jul 30$-11.55 vs $-9.80miss
- Wed, Apr 30$-7.70 vs $-11.90beat
Estimates and results for NVNO via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by NVNO officers and directors.
- Bought
- $538k
- Sold
- $455k
16 trades
14 trades
- Duhay Francissold
- Duhay Francissold
- Duhay Francissold
- Duhay Francissold
- Duhay Francisbought
- Gray Robertbought
- Shrivastava Sanjaybought
- Jenusaitis Matthewbought
70 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in NVNO.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.